Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-03-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1173490/full |
| _version_ | 1811158952966094848 |
|---|---|
| author | Frontiers Production Office |
| author_facet | Frontiers Production Office |
| author_sort | Frontiers Production Office |
| collection | DOAJ |
| first_indexed | 2024-04-10T05:33:03Z |
| format | Article |
| id | doaj.art-0e1baf24797c4eb7ac5d1c209b88b255 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-04-10T05:33:03Z |
| publishDate | 2023-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-0e1baf24797c4eb7ac5d1c209b88b2552023-03-07T05:01:20ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-03-011410.3389/fphar.2023.11734901173490Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors Frontiers Production Officehttps://www.frontiersin.org/articles/10.3389/fphar.2023.1173490/fullWnt signalingtriple-negative breast cancerβ-catenincancer survivalmedicinal chemistrystructure activity relationship |
| spellingShingle | Frontiers Production Office Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors Frontiers in Pharmacology Wnt signaling triple-negative breast cancer β-catenin cancer survival medicinal chemistry structure activity relationship |
| title | Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors |
| title_full | Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors |
| title_fullStr | Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors |
| title_full_unstemmed | Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors |
| title_short | Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors |
| title_sort | erratum wnt pathway inhibitors with selective activity against triple negative breast cancer from thienopyrimidine to quinazoline inhibitors |
| topic | Wnt signaling triple-negative breast cancer β-catenin cancer survival medicinal chemistry structure activity relationship |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2023.1173490/full |
| work_keys_str_mv | AT frontiersproductionoffice erratumwntpathwayinhibitorswithselectiveactivityagainsttriplenegativebreastcancerfromthienopyrimidinetoquinazolineinhibitors |